Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...

Novo Nordisk (NVO) and Eli Lilly (LLY) stocks are in focus as the duo plan to launch direct sales of weight loss drugs to ...

Bayer opened a new biotech incubator in Beijing. A first-of-its-kind biosimilar originally developed by Shanghai Henlius ...

FDA decision-making may be reduced to a sequence of ‘make-a-deals’ with Trump, his FDA, or even political allies,” experts ...

Findings show that inclusive attitudes among Italian oncologists coexist with clear knowledge and awareness gaps highlighting ...

A new weight-loss drug working through a different hormone pathway is raising interest among specialists who say it could ...

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, ...

Apple became the first $1 trillion company on U.S. public markets in 2018. Six of the eight companies to follow in Apple’s ...

Studies from Novo Nordisk due early next month will give the strongest indication yet of whether blockbuster GLP-1 drugs - a ...

But these eye-popping innovations have an effect only if they can make their way to the patients who need them. That reality ...

Wellgistics Health, Inc. ("Wellgistics") (NASDAQ:WGRX), a health information technology leader at the nexus of serialization ...